Analyses of placental gene expression in pregnancy-related hypertensive disorders

Taiwanese Journal of Obstetrics and Gynecology

Volumn 50, Issue 3, 2011, Pages 283-291

  Chang, Shuenn Dyh ^a   Chao, An Shine ^a   Peng, Hsiu Huei ^a   Chang, Yao Lung ^a   Wang, Chao Ning ^a   Cheng, Po Jen ^a   Lee, Yun Shien ^b,c   Chao, Angel ^a   Wang, Tzu Hao ^a,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b MING CHUAN UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Gene expression; Hypertensive disorders; Microarray; Preeclampsia; Pregnancy

Indexed keywords

ENDOGLIN; NITRIC OXIDE SYNTHASE;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN TISSUE; MATERNAL HYPERTENSION; MICROARRAY ANALYSIS; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPERIMPOSED PREECLAMPSIA ON CHRONIC HYPERTENSION; TRANSCRIPTION REGULATION; VASODILATATION;

ADULT; CHRONIC DISEASE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TAIWAN; UP-REGULATION;

EID: 82455212131     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2011.07.005     Document Type: Article

References (39)

1. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
2. Sattar N., Greer I.A. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?. BMJ 2002, 325:157-160.
3. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002, 2:656-663.
4. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005, 5:201-214.
5. Moffett A., Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006, 6:584-594.
6. McMaster M.T., Zhou Y., Fisher S.J. Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol 2004, 24:540-547.
7. Li H., Gu B., Zhang Y., Lewis D.F., Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005, 26:210-217.
8. Redman C.W., Sargent I.L. Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594.
9. Toft J.H., Lian I.A., Tarca A.L., Erez O., Espinoza J., Eide I.P., et al. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies. J Matern Fetal Neonatal Med 2008, 21:267-273.
10. Cunningham F.G., Grant N.F., Leveno K.J., Gilstrap L.C., Hauth J.C., Wenstrom K.D. Hypertensive disorders in pregnancy. Williams obstetrics 2001, 567-618. McGraw-Hill, New York. 21st ed.
11. Brazma A., Hingamp P., Quackenbush J., Sherlock G., Spellman P., Stoeckert C., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001, 29:365-371.
12. Brazma A., Parkinson H., Sarkans U., Shojatalab M., Vilo J., Abeygunawardena N., et al. ArrayExpress-a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 2003, 31:68-71.
13. Wang T.H., Lee Y.S., Chen E.S., Kong W.H., Chen L.K., Hsueh D.W., et al. Establishment of cDNA microarray analysis at the Genomic Medicine Research Core Laboratory (GMRCL) of Chang Gung Memorial Hospital. Chang Gung Med J 2004, 27:243-260.
14. Lee Y.S., Chen C.H., Chao A., Chen E.S., Wei M.L., Chen L.K., et al. Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV). BMC Genomics 2005, 6:132.
15. Chao A., Wang T.H., Lee Y.S., Hsueh S., Chao A.S., Chang T.C., et al. Molecular characterization of adenocarcinoma and squamous carcinoma of the uterine cervix using microarray analysis of gene expression. Int J Cancer 2006, 119:91-98.
16. Wang T.H., Chan Y.H., Chen C.W., Kung W.H., Lee Y.S., Wang S.T., et al. Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways. Oncogene 2006, 25:4857-4866.
17. Vinciotti V., Khanin R., D'Alimonte D., Liu X., Cattini N., Hotchkiss G., et al. An experimental evaluation of a loop versus a reference design for two-channel microarrays. Bioinformatics 2005, 21:492-501.
18. Nikolsky Y., Ekins S., Nikolskaya T., Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005, 158:20-29.
19. Mason C.W., Swaan P.W., Weiner C.P. Identification of interactive gene networks: a novel approach in gene array profiling of myometrial events during guinea pig pregnancy. Am J Obstet Gynecol 2006, 194:1513-1523.
20. Sood R., Zehnder J.L., Druzin M.L., Brown P.O. Gene expression patterns in human placenta. Proc Natl Acad Sci U S A 2006, 103:5478-5483.
21. Wang T.H., Chao A. Microarray analysis of gene expression of cancer to guide the use of chemotherapeutics. Taiwan J Obstet Gynecol 2007, 46:222-229.
22. Yauk C.L., Berndt M.L., Williams A., Douglas G.R. Comprehensive comparison of six microarray technologies. Nucleic Acids Res 2004, 32:e124.
23. Carter S.L., Eklund A.C., Mecham B.H., Kohane I.S., Szallasi Z. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements. BMC Bioinformatics 2005, 6:107.
24. Wang H., He X., Band M., Wilson C., Liu L. A study of inter-lab and inter-platform agreement of DNA microarray data. BMC Genomics 2005, 6:71.
25. Soleymanlou N., Jurisica I., Nevo O., Ietta F., Zhang X., Zamudio S., et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 2005, 90:4299-4308.
26. Reddy A., Suri S., Sargent I.L., Redman C.W., Muttukrishna S. Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia. PLoS One 2009, 4:e4453.
27. Sitras V., Paulssen R.H., Gronaas H., Leirvik J., Hanssen T.A., Vartun A., et al. Differential placental gene expression in severe preeclampsia. Placenta 2009, 30:424-433.
28. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649.
29. Tsai M.S., Hwang S.M., Chen K.D., Lee Y.S., Hsu L.W., Chang Y.J., et al. Functional network analysis on the transcriptomes of mesenchymal stem cells derived from amniotic fluid, amniotic membrane, cord blood, and bone marrow. Stem Cells 2007, 25:2511-2523.
30. Chao A., Wang T.H., Lee Y.S., Hong J.H., Tsai C.N., Chen C.K., et al. Analysis of functional groups of differentially expressed genes in the peripheral blood of patients with cervical cancer undergoing concurrent chemoradiation treatment. Radiat Res 2008, 169:76-86.
31. Wang T.H., Chao A.S., Chen J.K., Chao A., Chang Y.L., Cheng P.J., et al. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil Steril 2009, 92:96-107.
32. Wang C.N., Chang S.D., Peng H.H., Lee Y.S., Chang Y.L., Cheng P.J., et al. Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction. J Clin Endocrinol Metab 2010, 95:1431-1441.
33. Matsubara S., Takizawa T., Suzuki T., Minakami H. Sato I glucose-6-phosphate dehydrogenase is present in normal and pre-eclamptic placental trophoblasts: ultrastructural enzyme-histochemical evidence. Placenta 2001, 22:90-95.
34. Afzal-Ahmed I., Mann G.E., Shennan A.H., Poston L., Naftalin R.J. Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells. Free Radic Biol Med 2007, 42:1781-1790.
35. Toporsian M., Gros R., Kabir M.G., Vera S., Govindaraju K., Eidelman D.H., et al. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res 2005, 96:684-692.
36. Bernabeu C., Conley B.A., Vary C.P. Novel biochemical pathways of endoglin in vascular cell physiology. J Cell Biochem 2007, 102:1375-1388.
37. Guo B., Slevin M., Li C., Parameshwar S., Liu D., Kumar P., et al. CD105 inhibits transforming growth factor-beta-Smad3 signalling. Anticancer Res 2004, 24:1337-1345.
38. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
39. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683.